Markets
Superstars
Analyst Estimates
Alerts
Screeners
Subscribe
Calendar
ETFs
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
Explore
FAQs
Widgets
More
Search stocks
IND
USA
USA
USA
×
Close
IND
USA
Stocks
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Stocks
Foghorn Therapeutics Inc
Swot
Foghorn Therapeutics Inc SWOT Analysis: Strengths, Weakness, Opportunity, and Threats
Foghorn Therapeutics Inc has 11 Strengths, 7 Weaknesses, 1 Opportunities and 2 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential
Add SWOT widget to your site/app
Strengths
(11)
Weakness
(7)
Opportunity
(1)
Threats
(2)
Others
(0)
Price crossing above SMA20 today, and greater than SMA5
Stocks whose current price is 20% higher than week low, and more than previous close
Annual Profit Growth higher than Sector Profit Growth
PEG lower than Industry PEG
Good Aggregate Candlestick Strength (total bullish - bearish candlesticks)
Relative Outperformance versus Industry over 1 Week
Annual Net Profits improving for last 2 years
Top Gainers
Stock with Low PE (PE < = 10)
Volume Shockers
Biggest Price Gainers from Open
Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Inefficient use of assets to generate profits - ROA declining in the last 2 years
Highest fall from 52 Week High
Low Piotroski Score : Companies with weak financials
Declining Net Cash Flow : Companies not able to generate net cash
Stocks Underperforming their Industry Price Change in the Quarter
Mutual Funds Increased Shareholding in Past Month
MFs decreased their shareholding last quarter
Institutions decreased their shareholding last quarter
